Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Zai Lab Ltd (ZLAB) Cash Flow Statement

Zai Lab Ltd (ZLAB) generated -$133.4M of operating cash flow over the twelve months to 2026-06-30, spent $6.2M on capital expenditure and had free cash flow of -$139.6M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ZLABZai Lab LtdFollow ZLAB — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
2.7B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days
LineFY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-0.10-0.19-0.22-0.55-0.37-0.20-0.21-0.15-0.13
Capital expenditure0.010.010.010.020.020.010.010.01-0.01
Free cash flow-0.11-0.20-0.23-0.57-0.39-0.21-0.22-0.16-0.14
Stock-based compensation0.010.020.020.040.060.080.070.07—

USD billions · SEC XBRL

Zai Lab Ltd — questions

What is Zai Lab Ltd's operating cash flow?
-$133.4M over the twelve months to 2026-06-30.
How much does Zai Lab Ltd spend on capital expenditure?
$6.2M over the twelve months to 2026-06-30.
What is Zai Lab Ltd's free cash flow?
-$139.6M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Zai Lab Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.